ICCR meeting outcome
This article was originally published in The Rose Sheet
Executive Summary
FDA announces the availability of a document detailing the outcome of the International Cooperation on Cosmetic Regulation meeting, held in Brussels in September, in a March 7 Federal Register 1notice. The announcement is in keeping with FDA's commitment to transparency, and the agency will accept comments on the document until July 2, 2008. Cosmetic labeling and nanotechnology were among the issues discussed at the meeting, which included regulators from the U.S., Canada, the EU and Japan (2"The Rose Sheet" Oct. 15, 2007, p. 4)...
You may also be interested in...
ICCR Addresses Cosmetic Labeling, Nanotechnology At First Meeting
The International Cooperation on Cosmetics Regulation invites the cosmetics industry to generate and submit data showing that U.S. consumers understand the meaning of "trivial names" on product labeling
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.